PB-01 (Primo Biotechnology)

N/A

Report date: 2025/11/19 17:57:55
NME

Base Information

Drug NamePB-01 (Primo Biotechnology)
Drug Alias Name氟[18]-PSMA-1007Fluorine-18-PSMA-1007Fluorine[18]-PSMA-1007Radelumin18F-PSMA-1007 +[13] 
ClassificationDiagnostic agent (In vivo)Radiation-emitting products > Radioactive diagnostic agentRadiation-emitting products > Nuclides > Fluorine > 18F +[5] 
Mechanisms of ActionProstate-Specific Membrane Antigen inhibitors
TargetsProstate-Specific Membrane Antigen
Therapy Area/IndicationsProstatic NeoplasmsColonic NeoplasmsCarcinoma, Renal Cell
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryCanadaUnited StatesNetherlands +[11] 
CombinationsNo
Global Highest StatusApproved
Highest Status in ChinaN/A
Originator CompaniesPrimo Biotechnology Co Ltd
China Registration ClassN/A

Develop Information

Active CompaniesAbx Advanced Biochemical Compounds GmbhWestern UniversityPrimo Biotechnology Co Ltd +[4] 
Inactive CompaniesAHS Cancer Control Alberta
Active IndicationsProstatic NeoplasmsColonic NeoplasmsCarcinoma, Renal Cell
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A